Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 129

1.

Identification of candidate genes involved in clinical variability among Tunisian patients with β-thalassemia.

Mejri A, Siala H, Ouali F, Bibi A, Messaoud T.

Gene. 2012 Sep 10;506(1):166-72. doi: 10.1016/j.gene.2012.06.078.

PMID:
22771911
2.

Molecular characterization of β-thalassemia intermedia: a report from Iran.

Arab A, Karimipoor M, Rajabi A, Hamid M, Arjmandi S, Zeinali S.

Mol Biol Rep. 2011 Oct;38(7):4321-6. doi: 10.1007/s11033-010-0557-5.

PMID:
21120615
3.

Association between clinical expression and molecular heterogeneity in β-thalassemia Tunisian patients.

Jouini L, Sahli CA, Laaouini N, Ouali F, Ben Youssef I, Dakhlaoui B, Othmeni R, Ouennich F, Hadj Fredj S, Siala H, Becher M, Toumi NE, Fattoum S, Hafsia R, Bibi A, Messaoud T.

Mol Biol Rep. 2013 Nov;40(11):6205-12. doi: 10.1007/s11033-013-2732-y.

PMID:
24065537
4.

Molecular Basis of β-Thalassemia Intermedia in Erbil Province of Iraqi Kurdistan.

Shamoon RP, Al-Allawi NA, Cappellini MD, Di Pierro E, Brancaleoni V, Granata F.

Hemoglobin. 2015;39(3):178-83. doi: 10.3109/03630269.2015.1032415.

PMID:
25902180
5.

Molecular basis of thalassemia intermedia in Iran.

Akbari MT, Izadi P, Izadyar M, Kyriacou K, Kleanthous M.

Hemoglobin. 2008;32(5):462-70. doi: 10.1080/03630260802341851.

PMID:
18932071
6.

Molecular mechanisms underlying thalassemia intermedia in Iran.

Neishabury M, Azarkeivan A, Oberkanins C, Esteghamat F, Amirizadeh N, Najmabadi H.

Genet Test. 2008 Dec;12(4):549-56. doi: 10.1089/gte.2008.0018.

PMID:
18939939
7.

Extended molecular spectrum of beta- and alpha-thalassemia in Oman.

Hassan SM, Hamza N, Jaffer Al-Lawatiya F, Jaffer Mohammed A, Harteveld CL, Rajab A, Giordano PC.

Hemoglobin. 2010 Jan;34(2):127-34. doi: 10.3109/03630261003673147.

PMID:
20353347
8.

Molecular, hematological and clinical aspects of thalassemia major and thalassemia intermedia associated with Hb E-beta-thalassemia in Northeast Thailand.

Nuntakarn L, Fucharoen S, Fucharoen G, Sanchaisuriya K, Jetsrisuparb A, Wiangnon S.

Blood Cells Mol Dis. 2009 Jan-Feb;42(1):32-5. doi: 10.1016/j.bcmd.2008.09.002.

PMID:
18951049
9.

The molecular basis of beta-thalassemia intermedia in southern China: genotypic heterogeneity and phenotypic diversity.

Chen W, Zhang X, Shang X, Cai R, Li L, Zhou T, Sun M, Xiong F, Xu X.

BMC Med Genet. 2010 Feb 25;11:31. doi: 10.1186/1471-2350-11-31.

10.

Genetic factors affecting clinical severity in beta-thalassemia syndromes.

Winichagoon P, Fucharoen S, Chen P, Wasi P.

J Pediatr Hematol Oncol. 2000 Nov-Dec;22(6):573-80. Review.

PMID:
11132233
12.

Genotype-phenotype correlation and report of novel mutations in β-globin gene in thalassemia patients.

Nagar R, Sinha S, Raman R.

Blood Cells Mol Dis. 2015 Jun;55(1):10-4. doi: 10.1016/j.bcmd.2015.03.005.

PMID:
25976460
13.

Molecular pathogenesis and clinical variability of beta-thalassemia syndromes among Indians.

Nadkarni A, Gorakshakar AC, Lu CY, Krishnamoorthy R, Ghosh K, Colah R, Mohanty D.

Am J Hematol. 2001 Oct;68(2):75-80.

PMID:
11559945
14.
15.

Analyzing 5'HS3 and 5'HS4 LCR core regions and NF-E2 in Iranian thalassemia intermedia patients with normal or carrier status for beta-globin mutations.

Neishabury M, Azarkeivan A, Oberkanins C, Abedini SS, Zamani S, Najmabadi H.

Blood Cells Mol Dis. 2011 Mar 15;46(3):201-5. doi: 10.1016/j.bcmd.2010.12.007.

PMID:
21232998
16.

The modifying effect of Xmn1-HBG2 on thalassemic phenotype is associated with its linked elements in the beta globin locus control region, including the palindromic site at 5'HS4.

Neishabury M, Zamani S, Azarkeivan A, Abedini SS, Darvish H, Zamani F, Najmabadi H.

Blood Cells Mol Dis. 2012 Jan 15;48(1):1-5. doi: 10.1016/j.bcmd.2011.10.001.

PMID:
22036762
17.

Genotype-phenotype relationship of patients with β-thalassemia taking hydroxyurea: a 13-year experience in Iran.

Karimi M, Haghpanah S, Farhadi A, Yavarian M.

Int J Hematol. 2012 Jan;95(1):51-6. doi: 10.1007/s12185-011-0985-6.

PMID:
22180324
18.

Effect of a group of genetic markers around the 5' regulatory regions of the β globin gene cluster linked to high HbF on the clinical severity of β thalassemia.

Dabke P, Colah RB, Ghosh K, Nadkarni A.

Blood Cells Mol Dis. 2013 Mar;50(3):156-60. doi: 10.1016/j.bcmd.2012.11.003.

PMID:
23211376
19.

Molecular spectrum of α- and β-globin gene mutations detected in the population of Guangxi Zhuang Autonomous Region, People's Republic of China.

Zheng CG, Liu M, Du J, Chen K, Yang Y, Yang Z.

Hemoglobin. 2011;35(1):28-39. doi: 10.3109/03630269.2010.547429.

PMID:
21250879
20.

Molecular analysis of gamma-globin promoters, HS-111 and 3'HS1, in beta-thalassemia intermedia patients associated with high levels of Hb F.

Hamid M, Mahjoubi F, Akbari MT, Arab A, Zeinali S, Karimipoor M.

Hemoglobin. 2009;33(6):428-38. doi: 10.3109/03630260903336479.

PMID:
19958188
Items per page

Supplemental Content

Support Center